ArticleNature communications2022

Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up.

Michal Canetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.